Brief: CERo Therapeutics, Inc. Announces Financing and Provides Update on Investigational New Drug Application for CER-1236

CERo Therapeutics Holdings

25/09/2024 14:20

Sept 25 (Reuters) - CERo Therapeutics Holdings Inc
 CERO.O :
    * CERO THERAPEUTICS, INC. ANNOUNCES FINANCING AND PROVIDES
UPDATE
ON INVESTIGATIONAL NEW DRUG APPLICATION FOR CER-1236
    * CERO THERAPEUTICS HOLDINGS INC - REQUESTS TYPE A MEETING
WITH
FDA FOR CER-1236 CLINICAL HOLD
    * CERO THERAPEUTICS HOLDINGS INC - CHRIS EHRLICH APPOINTED
CHAIRMAN AND INTERIM CEO OF CERO
    * CERO THERAPEUTICS HOLDINGS INC - CFO CHARLES CARTER AND
CTO
DANIEL COREY STEP DOWN FROM CERO
    * CERO THERAPEUTICS HOLDINGS INC - SECURES $1.25 MILLION
FINANCING
FROM EXISTING INVESTORS

Source text for Eikon:  ID:nGNX84D6kb 
Further company coverage:  CERO.O 

 ((Reuters.Briefs@thomsonreuters.com;))